top of page

Pioneering Peptide Engineering

Advanced GLP-1 Solutions for Weight Management & Wellness

We Are Shaping the Future of Metabolic Health

Transforming the Future of Health Care with Advanced GLP-1 & GIP Therapies.

Welcome to a new era of wellness. We specialize in next-generation peptide therapies—Semaglutide and Tirzepatide—that are changing the way people approach weight management and metabolic health. Backed by science and driven by innovation, our brand stands for trust, transparency, and transformation.

Research & Technology

We apply cutting-edge biotechnology to deliver accurate insights and therapeutic innovation.

1

Next-Generation Metabolic Therapy

Our mission is to advance health through science. By focusing on innovative peptide therapies such as Semaglutide and Tirzepatide, we provide proven solutions for weight management and metabolic wellness. What sets us apart is our commitment to clinical precision, transparency, and results that truly improve lives.

2

GLP-1 & GIP Therapy

We specialize in next-generation peptide therapies designed to transform health and wellness. By focusing on Semaglutide and Tirzepatide, our mission is to deliver clinically proven solutions for weight management and metabolic balance. What makes us unique is our dedication to science, safety, and long-term results you can trust.

3

Drug Discovery & Delivery

At the heart of our work is the mission to make advanced therapies more accessible. We specialize in creating next-generation pharmaceuticals that address real health challenges with precision, safety, and innovation. Our approach ensures lasting impact, improving wellness and quality of life for the people we serve.

What Makes Us Unique

Research. Progress. Humanity.

GLP-1 therapies such as semaglutide have been studied for over a decade and widely used in the treatment of type 2 diabetes. Their long history of clinical research and patient use provides strong evidence of both safety and effectiveness, making them a reliable foundation for modern metabolic health solutions.

Tirzaglix™ (Tirzepatide) 10 mg is a next-generation dual GIP and GLP-1 receptor agonist, clinically proven to support significant weight reduction and improved metabolic control.

tirzepatidewebFINAL.png

Fortex Clinic in Numbers

9

Ongoing Research Programs

35

Employees

7

Publications

11

Partners Worldwide

Join Our Team

We are seeking strategic partners worldwide to join us on our mission of advancing health through innovation. We invite you to connect with us and explore opportunities to grow together. Become part of a trusted network that is shaping the future of wellness on an international scale.

bottom of page